Skip to main content
Fig. 4 | Lipids in Health and Disease

Fig. 4

From: Decreased circulating dihomo-gamma-linolenic acid levels are associated with total mortality in patients with acute cardiovascular disease and acute decompensated heart failure

Fig. 4

Event-free survival curves for all-cause death in patients with acute decompensated heart failure (ADHF). Unadjusted cumulative event rates for the primary endpoint (all-cause death) were estimated using the Kaplan–Meier method and compared between groups using the log-rank test. We defined cut-offs as the median levels of polyunsaturated fatty acids [ADHF: dihomo-gamma-linolenic acid (DGLA), 22.1 μg/ml; arachidonic acid (AA), 147.2 μg/ml; eicosapentaenoic acid (EPA), 38.2 μg/ml; docosahexaenoic acid (DHA), 113.3 μg/ml; DGLA/AA, 0.15; and EPA/AA, 0.27 and acute coronary syndrome: DGLA, 32.1 μg/ml; AA, 173.0 μg/ml; EPA, 50.7 μg/ml; DHA, 128.8 μg/ml; DGLA/AA, 0.20; and EPA/AA, 0.31]

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X